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A review of factors altering the safety margin between
a therapeutic and a toxic dose of digitalis includes the
consideration of: l) clinical conditions to which digitalis
action may be undesirable, 2) allergy and hypersensi-
tivity to digitalis, 3) physiologic factors modifying tol-
erance to digitalis, 4) factors that change the amount of
digitalis in the body, 5) nervous and metabolic factors
modifying tolerance to digitalis, 6) modifications of dig-
italis tolerance produced by the status of the myocar-
dium, and 7) modifications of digitalis tolerance produced
The purpose of this report is to review the factors that cause
altered tolerance to digitalis. defined as a change in the
safety margin between a therapeutic and a toxic dose or
between a toxic and a lethal dose. An increased tolerance
signifies the need for larger than customary doses to produce
the desired effect. Conversely. a decreased tolerance means
that smaller than customary doses will produce an undesir-
able effect. The understanding of the factors altering the
digitalis tolerance and requirements shouldenhance the safety
and effectiveness of digitalis therapy. Many important as-
pects of this subject, such as the interaction of digitalis with
other drugs or the mechanisms underlying therapeutic and
toxic effects of glycosides, are discussed elsewhere in this
symposium and also in a recent, two part, comprehensive
overview of the subject (1,2) .
Physicians administering digitalis are much more often
confronted with the problems of toxicity than with those of
resistance to treatment. To the best of my knowledge. the
development of tachyphylaxis to digitalis has not been re-
ported. This may be due to its absence or to the metho-
dologic difficulties in documenting such a phenomenon in
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by diseases of other organs. The problems related to
digitalis toxicity are more common than those of resist-
ance to treatment. The most important factors contrib-
uting to decreased tolerance and risk of toxicity are:
heart disease, poor renal function, hypokalemia and hy-
pothyroidism.The rolesofimpaired liverfun~tion, chronic
lung disease, acid-base disturbances, anesthesia, auto-
nomic imbalance, calcium and magnesium are less im-
portant and less well established.
(J Am Coll Cardiol 1985;5:69A-81A)
clinical practice. A small fraction of patients receiving dig-
italis may have an unusually high tolerance that cannot be
explained by any of the known factors (3). This group in-
cludes certain patients with atrial fibrillation or flutter and
supraventricular tachycardia who require unusually large
doses to slow the ventricular rate. possibly as a result of
abnormal electrophysiologic properties of the atrioventric-
ular (AV) node. It has been suggested that patients who
tolerate unusually large doses of digitalis probably have a
healthy myocardium (3). It remains to beestablished whether
the extremes of tolerance represent some abnormality of
metabolism of glycosides or some difference in tissue re-
sponse. In the vast majority of patients receiving digitalis,
the changes in "sensitivity" can be explained adequately
by the factors in the following discussion. as well as those
listed in Table I.
The estimated incidence of cardiac toxicity in hospital
patients treated with digitalis before the widespread use of
serum digoxin and digitoxin concentrations was 12 to 20%
(references in reference 4). The determination of serum
digoxin concentrations has contributed to decreased inci-
dence of digoxin toxicity (1,2). In a recent study (5) of 437
patients in whom treatment with digitalis was monitored,
adverse reactions occurred in 19.5% of patients. However,
these reactions were relatively benign, and no deaths were
attributed to digitalis (5). This apparent trend toward in-
creasing safety was attributed to better education and im-
proved bioavailability of digoxin. which is the most com-
monly used digitalis preparation in the United States.
The end point for assessing the drug tolerance is usually
the evidence of digitalis toxicity, a condition lacking precise
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Possible Reasons for Increased Sensitivity
Cardiac
Increased automaticity of ectopic pacemakers
Heart disease*
Heart surgery*
Low potassium*
Chronic lung disease (?)
Catecholamines and sympathetic stimulationt
Impaired SAN function and AV conduction
Increased vagal activity
Decreased sympathetic activity
Heart disease*
Heart surgery*
Low potassium*
High potassium
Impaired degradation or excretion
Hypothyroidism*
Renal disease*
Liver disease
Premature infants *
Old age (?)
Interaction with drugs
Extracardiac
Allergy and hypersensitivity
CNS disorders
Low weight
Possible Reasons for Increased Tolerance
Decreased automaticity of ectopic pacemakers
High potassium*
Antiarrhythmic drugst
Vagal stimulation
Decreased vagal or increased sympathetic activity
Fever, infection, hypoxia, hyperkinetic states (?)
Hyperthyroidism"
Normal infants and young children
Decreased absorption or unusual losses
Malabsorption
Dialysis (?)
Cardiac bypass C!)
*Factors that appear to be of greatest practical importance. tVariable effects. C!) Inconclusive evidence.
AV = atrioventricular; CNS = central nervous system; SAN = sinoatrial node.
definition because of the nonspecificity of various "toxic"
symptoms. The latter frequently resemble symptoms of un-
derlying heart disease or those of other systems. The long
list of toxic digitalis effects includes such nonspecific man-
ifestations as increasing severity of congestive heart failure,
acute hemorrhage and necrosis of the intestines, fatigue,
headache, vertigo, confusion, depression, delirium and con-
vulsions (references in reference 4).
Similarly, the disturbances of rhythm and conduction
caused by digitalis are not specific. Arrhythmia in patients
treated with digitalis may be due to the drug, the underlying
heart disease, associated metabolic disturbances or treatment
with other drugs. The evaluation of digitalis tolerance may
be also difficult when different preparations produce dif-
ferent toxic manifestations in the same individual. Thus,
the difficulty in the evaluation of digitalis tolerance in pa-
tients may be responsible for some of the conflicting and
confusing observations reported to date.
The following categories of factors that alter digitalis
tolerance will be considered: I) clinical conditions in which
digitalis action may be undesirable, 2) allergy and hyper-
sensitivity to digitalis, 3) physiologic factors modifying tol-
erance to digitalis, 4) factors that change the amount of
digitalis in the body, 5) nervous and metabolic factors mod-
ifying tolerance to digitalis, 6) modifications of digitalis
tolerance produced by the status of the myocardium, and
7) modifications of digitalis tolerance produced by diseases
of organs other than the heart.
Conditions in Which Digitalis Action
May Be Undesirable
In patients with hypertrophic cardiomyopathy, the pos-
itive inotropic action of digitalis may increase the subaortic
obstruction, diminish the effective orifice of the left ven-
tricular outflow tract (6) and contribute to "cavity obliter-
ation." The condition of some of these patients has been
shown to deteriorate after digitalis administration and to
improve when digitalis is discontinued. Bradycardia due to
the vagal action of digitalis may cause a decreased cardiac
output in patients with a fixed stroke volume, for example,
patients with constrictive pericarditis. Also, the shortening
of the refractory period in the accessory AV pathway by
digitalis may be harmful in patients with atrial tachycardia
or fibrillation or flutter if the atrial impulses are conducted
through an accessory pathway with a preexisting short re-
fractory period.
Allergy and Hypersensitivity to Digitalis
Isolated cases of idiosyncratic response to digitalis re-
sulting in urticaria, scarlatiniform exanthema, papules, ves-
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icles, purpura, bullae, angioneurotic edema, eosinophilia or
thrombocytopenic purpura have been reported (4,7). Some
of the patients allergic to digitalis have positive skin tests
for the drug (8).
Physiologic Factors Modifying
Tolerance to Digitalis
Age. Children between the ages of I month and 2 years
tolerate more glycosides per unit of body weight than do
older children and adults (4,9-11). This increased tolerance
in younger children has been attributed to a greater heart/body
weight ratio (12). However, it appears that digitalis require-
ment is correlated with body surface area rather than weight.
Thus, children and adults weighing from 5 to 70 kg require
the same therapeutic digitoxin dose per unit of body surface
(9).
Premature and newborn infants tolerate less digitalis per
unit of body weight than do children between the ages of I
month and 2 years. The decreased tolerance in premature
and young infants has been attributed to immaturity of he-
patic and renal function and the resulting impairment of
metabolism and excretion (II). The manifestations of dig-
italis overdosage in children are different from those in
adults (12). In children, ventricular ectopic complexes occur
less frequently than sinus bradycardia, sinoatrial block and
ectopic atrial or AV junctional escape rhythms.
Many clinicians feel that old age lowers digitalis toler-
ance. Indeed, in old patients, the half-life of digoxin is
prolonged as a result of diminished urinary excretion as-
sociated with lower creatinine clearance and smaller body
size (13). Other factors may also operate. For instance, an
age-dependent decrease in the toxic ouabain dose in older
rabbits was associated with an apparent increase in ventric-
ular norepinephrine content (14). Age appears to have no
significant effect on digiioxin toxicity, probably because
elimination of digitoxin is less dependent on kidney function
than is elimination of digoxin.
Weight. There is no precise correlation between body
weight and tolerance to digitalis. However, there is a general
impression that patients with a larger body weight may
require larger amounts of digitalis, and that low weight is
associated with increased toxicity (15). It has been shown
( 16) that the dose of ouabain required to produce slowing
of the ventricular rate in the presence of atrial fibrillation
increases with increasing body weight.
Sex. The estrogen-like effect of digitalis may produce
gynecomastia in older men, and an estrogen effect on the
vaginal wall in oophorectomized and adrenalectomized mice
and postmenopausal women (4). Some investigators suggest
that gynecomastia in patients receiving digitalis is either
incidental (17) or related to impaired liver function (18).
However, prominent bilateral gynecomastia is known to
regress within a few weeks after cessation of digitalis ther-
apy (4). There is also suggestive evidence that estrogen may
protect against digitalis toxicity. Neutered female dogs treated
with estrogenic substances appeared to have a greater tol-
erance to digitalis than did male dogs or untreated neutered
female dogs (4).
There is no uniform agreement about the effect of gender
on digitalis. In one study (19) of 179 patients who had
absorbed more than 2 mg of digitoxin, the risk of death was
higher in men. In a retrospective study (20) comparing young
men and premenopausal women with rheumatic valvular
disease, the incidence of digitalis-induced arrhythmias was
20.6% in men and 10.2% in women. However, digitalis-
induced nausea and vomiting were more frequent in women
than in men, possibly indicating a greater sensitivity to
digitalis (5).
Blood group. Among digoxin-treated patients, there was
a statistically lower incidence of toxicity in patients with
blood group 0 (10%) than in those with groups A, Band
AB (16.3%, P < 0.002) (21).
Factors That Change the Amount of
Digitalis in the Body
The amount of digitalis in the body may be modified by
variations in absorption, metabolism, excretion or unusual
losses associated with dialysis, bleeding, pregnancy or car-
diopulmonary bypass. Left or right ventricular failure does
not impair digitalis absorption (22). The metabolism of di-
goxin is apparently not appreciably altered in patients with
a congested liver or alcoholic liver cirrhosis (15,23,24).
Impaired renal excretion. In patients with normal kid-
ney function, urinary renal excretion of digoxin is indepen-
dent of the glomerular filtration rate (1,2). However, in
patients with impaired renal function, digoxin elimination
parallels the creatinine clearance. Impaired excretion of di-
goxin and decreased digitalis tolerance in patients with renal
insufficiency have been well documented. Jelliffe and Brooker
(25) constructed a useful nomogram for calculating the ap-
propriate doses of digoxin based on renal function and body
weight. There are differences between tolerance to digoxin
and digitoxin, which is extensively metabolized in the liver.
Elimination of digitoxin is less dependent on kidney func-
tion, and this favors its use in patients with renal insufficiency.
Jaundice. Patients with jaundice, particularly those with
obstructive jaundice, frequently have bradycardia and in-
creased sensitivity to vagal stimulation. This may be due to
the effect of the retained bile acids which have a structure
similar to that of digitalis. Patients with obstructive jaundice
may have hypercholesterolemia. Hypercholesterolemic rab-
bits appeared to be more resistant to digitalis than did nor-
mocholesterolemic animals (26).
Dialysis. The amount of digitalis removed during peri-
toneal dialysis is small (27). It has been reported (28) that
the artificial kidney removes digoxin from plasma only one-
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tenth as effectively as normal kidneys. Blood contains rel-
atively small amounts of digitalis, and no large glycoside
losses are expected even with significant hemorrhage. Small
amounts of digitalis can cross the placental barrier (29).
Cardiopulmonary bypass. The loss of digitalis into the
pump oxygenator during cardiopulmonary bypass is also
small (30), but the effects of cardiopulmonary bypass on
digitalis tolerance are controversial. After bypass, undigi-
talized dogs have been reported to be more sensitive to
digitalis, but chronically digitalized dogs required more oua-
bain to produce an arrhythmia (31,32). In cardiac tissues,
radioactivity after cardiopulmonary bypass decreased by 23%
in dogs (31) and 10 to 28% in patients (33).
In human patients, myocardial sensitivity to the toxic
effects of digitalis was seen to increase in the first 24 hours
after cardiopulmbnary bypass (33). Toxicity was not related
to blood gas and serum electrolyte concentration values, and
arrhythmia occurred at serum digoxin levels that were within
normal range and lower than those in other patients with
arrhythmias due to digitalis toxicity (33).
Nervous Factors Modifying
Tolerance to Digitalis
Sympathetic stimulation and catecholamines. Both
sympathetic stimulation and catecholamines counteract the
antiadrenergic and vagal effects of digitalis. Figure I shows
an example of such interaction in a patient with atrial fi-
brillation. At rest, the slow ventricular rate and the ven-
tricular premature complexes appearing as a bigeminal rhythm
suggest digitalis toxicity, but after mild exercise the ven-
tricular rate is rapid and ventricular premature complexes
are no longer present. Patients who have fever, infection,
anxiety or hyperthyroidism, or who are performing exercise
require larger than ordinary doses of digitalis to slow the
ventricular rate in the presence of atrial fibrillation (4,34).
The slowing of ventricular rate produced by digitalis may
be reversed to a variable extent by the administration of
Figure 1. Electrocardiogram (lead Ill) of a 38 year old woman
withmitralstenosis and atrial fibrillation treated witha dailymain-
tenance dose of 0.5 mg of digoxin. At rest, ventricular ectopic
complexes appear partly as bigeminal rhythm. After a 30 yard
walk, ventricular rate is rapidand there are no ectopic complexes.
(Reproduced from Fisch C, Surawicz B [4] with permission.)
Rest
After walking 3Oyds.
epinephrine or stimulation of stellate ganglia (4). The cate-
cholamines augment the digitalis-induced increased auto-
maticity of ectopic pacemakers in Purkinje fibers (35,36),
and isoproterenol has been used to increase the ventricular
rate in patients with digitalis-induced depression of AV
conduction.
Isoproterenol increased ectopic activity in dogs receiving
digitalis. Both catecholamines and excessive doses of dig-
italis increase the temporal dispersion of excitability recov-
ery and, thus, facilitate ventricular fibrillation. However,
there is no convincing evidence that sympathetic stimulation
induces ventricular tachycardia or fibrillation in patients re-
ceiving digitalis. On the contrary, an intact sympathetic
activity appears to protect the myocardium from digitalis-
induced vulnerability (37).
Beta-adrenergic blocking agents have been reported to
augment the slowing of AV conduction produced by digi-
talis. They also prevent or suppress digitalis-induced ectopic
complexes and rhythms (38), suggesting that digitalis-in-
duced ectopic activity may be somehow related to sympa-
thetic stimulation or catecholamine release. However, the
suppression of ectopic activity by the beta-adrenergic block-
ing agents may be due not to sympathetic blockade, but
rather to a direct antiarrhythmic action of these agents (4).
Pretreatment with reserpine or guanethidine may prevent
the appearance of ectopic complexes or ventricular fibril-
lation induced by digitalis (4). However, acute or chronic
denervation of the heart and catecholamine depletion by
reserpine apparently do not alter the dose of digitalis re-
quired to produce ventricular ectopic complexes (39,40).
As might be expected, the effects of digitalis and reserpine
or guanethidine on AV conduction are synergistic, so that
smaller doses of digitalis may produce AV block after
administration of these agents (41).
In dogs. interruption of cardiac sympathetic innervation
by surgical procedures, spinal anesthesia, ganglionic block
or pretreatment with reserpine increased toxic and lethal
digitalis doses (42-45). Also, after spinal cord transection,
the lethal dose of ouabain was higher (43). Spinal cord
transection or propranolol treatment delayed the onset of
digoxin-induced arrhythmia, but failed to abolish the ar-
rhythmia threshold-lowering effect of left anterior descend-
ing coronary artery occlusion in anesthetized cats (44).
Vagal stimulation and ablation. Patients receiving dig-
italis become sensitive to carotid sinus massage or other
types of vagal stimulation (46). Response to carotid sinus
stimulation may occasionally provide the earliest evidence
of digitalis intoxication by inducing depression of sinoatrial
(SA) or AV conduction or by precipitating ventricular ec-
topic complexes or rhythms (46). The effect of carotid sinus
stimulation on the ventricular rate in patients with atrial
fibrillation receiving digitalis helps to assess the therapeutic
effects of digitalis. Another example of the synergistic ac-
tion of digitalis and vagal stimulation may be observed
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during treatment of refractory supraventricular paroxysmal
tachycardia, where digitalis becomes effective only after
pretreatment with neostigmine.
Removal ofparasympathetic innervation to the heart did
not modify ouabain toxicity (42). Similarly, bilateral va-
gotomy did not alter the enhancement of digoxin toxicity
caused by ligationof left anteriordescendingcoronaryartery
disease in the anesthetized cats (44).
Metabolic Factors Modifying
Tolerance to Digitalis
Potassium. Increased extracellular potassium concen-
tration inhibits glycoside binding to Na+ -K+ adenosine tri-
phosphatase(ATPase), decreases the inotropiceffect of dig-
italis (I ,2) and suppresses digitalis-induced ectopic rhythms
(47). Accordingly, patients with hyperkalemiatolerate large
doses of digitalis without developing ectopic activity. Con-
versely, hypokalemia increases glycoside binding to Na' -
K+ -ATPase and potentiates toxic effects of digitalis (1,2).
In the presence of hypokalemia, ectopic complexes and
rhythms may appear after the administration of relatively
small glycoside doses (48). Also, in patients treated with
digitalis, arrhythmias may be precipitated by carbohydrate
administration, removal of potassium by dialysis (49-51)
and, most frequently, by treatment with diuretic drugs.
The interaction of potassium and digitalis on AV con-
duction reflects the complex effects of potassium on AV
conduction, which may be depressed by both low and high
potassium concentrations (52,53). Moderate hyperkalemia
may improve AV conduction in patients with digitalis-in-
duced AV block (54), but an opposite effect can occur as
a result of a synergistic depressive effect of hyperkalemia
on AV conduction, as reported in both dogs and human
patients (55-58). Therefore, the net effects of hyperkalemia
on AV conduction changes induced by digitalis are not
predictable in individual cases. Moreover, these effects de-
pend not only on the absolute plasma potassium concentra-
tion, but also on the rate of potassium administration and
the structural integrity of the AV junction. In patients with
atrial fibrillation treated with digitalis, hyperkalemia fre-
quently causes complete AV block. In patients with preex-
isting disease of the AV junction, the synergistic effects of
hyperkalemiaand digitalis on AV conduction may produce
severe bradycardia or asystole (59) . However, in patients
withoutpreexistingAV block, the rate of escape pacemakers
is either normal or rapid. Figure 2 shows an electrocardio-
gram from a patient with atrial fibrillation treated with a
daily maintenancedose of 0.25 mg of digoxin. An adequate
heart rate is maintained during hyperkalemia, even in the
presence of a regular wide QRS rhythm at a plasma potas-
sium concentration of 8.4 mEq/liter.
Hypokalemia may augment digitalis-induced depression
of AV conduction . The most characteristic arrhythmias in
hypokalemic patients treated with digitalis are ectopic atrial
tachycardia with block and nonparoxysmal AV junctional
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Figure 2. Electrocardiograms of a 58 year
old man with atrial fibrillation treated with a
maintenance digoxin dose of 0.25 mg daily
in the absence (12-28-66) and presence
(1-25-67) of hyperkalemia. which was treated
with glucose and insulin. Note the regular
wide QRS rhythm at a plasma potassium con-
centration (Kp) of 8.4 mEq/liter. GLUe.
glucose ; INSUL. = insulin; SENS. =
sensitivity .
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tachycardia with or without block; the latter occurs fre-
quently in the presence of atrial fibrillation. These types of
arrhythmia are caused by a combination of increased au-
tomaticity of ectopic pacemakers and depression of AV
conduction.
In general, there is a fairly wide margin of safety between
the depressant effects of potassium on AV nodal conduction
and automaticity of the escape pacemakers because of the
different effects of potassium on AV nodal and His-Purkinje
tissue. Thus, cautious administration of potassium is usually
safe in the management of serious digoxin-induced arrhyth-
mias which include AV conduction disturbances.
Both hypokalemia and digitalis shorten the effective re-
fractory period of the ventricles and, therefore, shorten the
coupling interval of the ventricular ectopic complexes. Slow
propagation of early premature ectopic impulses may result
in reentry and cause ventricular fibrillation. The synergistic
effect of hypokalemia and digitalis on automaticity of ec-
topic pacemakers and AV conduction explains the low dig-
italis tolerance of patients with hypokalemia. In these pa-
tients, ectopic atrial tachycardia with block or AV junctional
tachycardia may appear after the administration of 0.75 to
2.0 mg of digoxin (59). It has been shown that when patients
treated with digitalis and diuretic drugs were not receiving
potassium supplement, average plasma potassium concen-
tration decreased from 4.3 to 3.4 mEq/liter, total body po-
tassium decreased by 10% and arrhythmias appeared in 50%
of the individuals at an average serum digoxin concentration
of 1.52 ng/ml (60).
In vitro, increase of automaticity by ouabain due to en-
hanced phase 4 diastolic depolarization occurred more fre-
quently at (K +)0 of 2.5 roM/liter than at 4.0 to 5.0 roM/liter
(61). In hypokalemic dogs, digoxin toxicity occurred after
treatment with a dose that was 39% lower than that in
normokalemic animals (62). In hypokalemic dogs with dig-
italis toxicity, myocardial concentration was 33% less than
that of normokalemic dogs. Therefore, enhanced sensitivity
was not due to increased digoxin uptake by the heart (62).
In another study, hypokalemia induced by glucose and in-
sulin decreased the dose of digoxin required to produce
ventricular tachycardia. This was associated with more rapid
myocardial digoxin uptake and more rapid Na + -K + -ATPase
inhibition (63). Toxicity in this setting occurred earlier at a
lesser but a more rapidly developing Na+ -K+ -ATPase in-
hibition as a result of a more rapid glycoside uptake. How-
ever, studies (63,64) have also suggested an independent
contribution of membrane effects of hypokalemia to digitalis
toxicity, in addition to the toxic effects of Na + -K + -ATPase
inhibition (63,64). Also, the reduced renal excretion of di-
goxin during hypokalemia contributes to an increased serum
digoxin concentration (60).
Calcium. It has been reported that administration of cal-
cium may induce ventricular tachycardia and ventricular
fibrillation in patients treated with digitalis (65,66). How-
ever, in animals receiving digitalis, hypercalcemia produced
ectopic rhythms only when they had received in excess of
95% of the toxic dose of ouabain. Dogs that received 90%
of the toxic dose of acetylstrophanthidin had no arrhythmia
when serum calcium concentration was 46.2 mg/loo ml
(67). In another study (68), AV block occurred in nondi-
gitalized dogs at a serum calcium concentration of 15 to 40
mg/100 ml, and ectopic rhythms terminated in ventricular
fibrillation at slightly higher calcium concentrations (68).
In that study (68), the effects of calcium in digitalized and
nondigitalized animals were similar, and there was no clear
evidence of any synergistic or additive effect between cal-
cium and digitalis.
The divergent implications of the early clinical obser-
vations and those of the experimental studies in dogs may
be due to different rates of intravenous calcium administra-
tion. In the study of Nola et al. (69), the amount of ace-
tylstrophanthidin needed to produce arrhythmia was not sig-
nificantly different from control when serum calcium averaged
12.48 mEg/liter. However, at concentrations higher than
15.0 mEq/liter, less digitalis was needed to produce ar-
rhythmia. Such concentrations are not encountered in clin-
ical practice, but may be achieved during rapid intravenous
administration. The study suggests that it is advisable to
infuse calcium salts at a slower rate in patients treated with
digitalis to avoid marked transient hypercalcemia.
Magnesium. Magnesium-depleted animals appear to be
more sensitive to digitalis (70-73). Also, in dogs with hy-
pomagnesemia induced by dialysis utilizing the magnesium-
free dialyzate, the dose of toxic arrhythmia was reduced by
26% (74). In dogs with hypomagnesemia induced with fu-
rosemide treatment, sustained ventricular arrhythmia and
death occurred at significantly lower ouabain doses (75).
Hypomagnesemia also enhanced ouabain-induced automat-
icity in the presence of AV block (75).
In one study (76), hypomagnesemia was present in 21%
of patients with and in 10% of those without digitalis tox-
icity, but this difference was of borderline statistical sig-
nificance. In other studies, the prevalence of hypomagne-
semia in patients with digitalis toxicity (77) was not increased,
and there was no correlation between plasma magnesium
concentration and serum digitoxin (77) or digoxin (77,78).
Arrhythmias attributed to digitalis toxicity respond fa-
vorably to the intravenous administration of magnesium
sulfate (79,80), but this does not conclusively establish that
arrhythmia is caused by digitalis because of the well known
nonspecific antiarrhythmic effect of magnesium salts. It has
been shown that in patients in whom magnesium sulfate
suppressed digitalis-induced arrhythmias, there was no evi-
dence that the treatment reactivated Na + -K + -ATPase, al-
tered myocardial or microsomal digoxin binding or acted
through the autonomic nervous system (79).
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Acidosis and alkalosis. Since changes in pH are usually
associated with altered concentrations of potassium and ion-
ized calcium, the independent effects of acidosis or alkalosis
on digitalis tolerance may be difficult to identify (81,82) .
In anesthetized dogs, metabolic alkalosis (pH 0.757) did
not alter the amount of acetylstrophanthidin necessary to
produce digitalis toxicity, but prolonged the duration of
arrhythmia from an average of 19 to 52 minutes (83). As
may be expected , serum potassium concentration was in-
creased by digitalis and decreased by alkalosis.
The mean lethal dose of ouabain was decreased in the
presence of both respiratory and metabolic alkalosis (84).
This appeared to be independent of hypokalemia because
digitalis tolerance remained decreased when hypokalemia
was prevented by means of supplemental potassium feeding
(84) . Also, in patients with metabolic alkalosis and normal
plasma potassium concentrations, therapeutic digoxin con-
centrations «2.0 ng/ml) were associated with greater ar-
rhythmia prevalence than that in patients without alkalosis
(85). The mechanism of the apparent increased sensitivity
to digitalis in the presence of alkalosis without hypokalemia
is not certain.
Changes in P02 and PC02' In guinea pigs, the dose of
ouabain needed to produce toxic arrhythmia was increased
when animals were equilibrated with 100% oxygen at a
pressure of I atm, and protection increased further at pres-
sures of 2 and 3 atm. an effect attributed to the increased
amount of dissolved oxygen in the blood (86).
Similar to digitalis . hypoxia shortens the effective re-
fractory period and may increase automaticity. Dogs breath-
ing hypoxic air mixtures appeared to be more sensitive to
acetylstrophanthidin than were dogs breathing room air
(87,88) . However, the duration of toxic arrhythmia in dogs
during ventilation with room air did not differ from that
during hypoxia (Po, = 40 mm Hg) at the same potassium
concentration (87). In contrast to acute hypoxia, chronic
hypoxia after a stay of 2 weeks ina hypobaric chamber did
not change the average toxic dose of ouabain in conscious
dogs (89) . The effect of hypercapnia at Pco, of 60 mm Hg
and lactic acidosis at pH of 7.0 was studied in cats , and
neither intervention changed the inotropic response to dig-
italis (90).
Temperature. The effects of increased temperature are
difficult to separate from the effects of increased sympathetic
stimulation . Increased body temperature causes an increased
heart rate, more rapid AV conduction, a shorter effective
refractory period and possibly an increased automaticity of
the ectopic pacemakers. More ouabain was required to re-
duce the ventricular rate of patients with fever than was
required in patients without fever (16). However, in dogs,
both the toxic and the lethal doses of digitalis were lower
at higher body temperature (91) .
Moderate hypothermia seems to increase tolerance to
digitalis . Larger doses of acetylstrophanthidin were required
to induce ectopic complexes in hypothermic dogs (92). Also,
the lethal dose of digitalis in cats and dogs with a body
temperature reduced to 25 to 28°C was twice as large as in
normothermic animals (93,94).
Anesthesia. The results of interaction between anes-
thetic agents and digitalis in human beings are difficult to
evaluate because of the number of factors that may alter the
electrophysiologic properties of the heart during operation.
The anesthetic agents may have a direct effect on auto-
maticity and conduction, as well as an indirect effect sec-
ondary to altered myocardial contractility and ventilation .
In dogs, cyclopropane and digitalis had a synergistic
effect on automaticity, thiopenthal did not alter digitalis
tolerance compared with awake dogs and halothane in-
creased digitalis tolerance for both toxic and lethal doses
(95,96). This increased tolerance induced by halothane per-
sisted after bilateral vagotomy. In pentobarbital-anesthe-
tized dogs , ouabain tolerance was not modified by low and
moderate doses of norepinephrine, but was reduced by doses
exceeding I ILglkg per min (97). Pretreatment with phen-
obarbital was also observed to enhance digitoxin toxicity in
guinea pigs (98). In addition, it has been shown that sux-
amethonium given for endotracheal intubation may trigger
arrhythmias in digitalized patients with coronary artery dis-
ease (99), and that succinylcholine may increase digitalis-
induced ectopic complexes in animals and human beings
(100) .
To test the effect of ventilation during anesthesia in dogs
anesthetized with pentobarbital and morphine, a group of
spontaneously breathing hypoxic, hypercapnic and acidotic
animals was compared with a group of artificially ventilated
and adequately oxygenated dogs . Toxic and lethal ouabain
doses in these two groups were not different from each other,
and ouabain toxicity was not altered by pretreatment with
propranolol or reserpine in either group (10 I).
Electric shock. Administration of digitalis decreased the
amount of electrical energy required to produce ventricular
tachycardia or fibrillation by induction of shock during the
vulnerable period (102) . Synchronized direct current shock,
used for treatment of arrhythmias, frequently precipitated
supraventricular and ventricular ectopic complexes and
rhythms, including ventricular fibrillation in both animals
(103) and patients receiving digitalis (104-106). A more
recent study (107) in closed chest dogs, using different doses
of digoxin and graded external direct current shocks, showed
that despite a wide range of serum digoxin concentration
(1.3 to 12.5 ILg/ml) , the electric shocks caused no electro-
cardiographic signs of toxicity in any animals . However, in
two dogs with manifest electrocardiographic evidence of
digitalis toxicity, sustained ventricular tachycardia appeared
after electrical shocks at all energy levels. These investi-
gators (107)concluded that the risk of arrhythmia after direct
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current shock is increased in the presence of overt digitalis
toxicity, but not after pretreatment with apparently nontoxic
digoxin doses.
Status of the Myocardium
Normal versus diseased heart. Healthy adults can tol-
erate larger amounts of digitalis than can patients with heart
disease (17). In young adults without heart disease, exces-
sive doses of digitalis produce the same effects as in children
with heart disease, namely, sinus bradycardia, sinus ar-
rhythmia and AV conduction disturbances. Figure 3 shows
marked sinus bradycardia, AV conduction disturbances and
escape complexes in a young woman who attempted to
commit suicide by ingesting large amounts of digoxin. Atro-
pine restored sinus rhythm and shortened the PR interval,
suggesting that all the toxic effects of digitalis in this case
had been due to vagal stimulation. Figure 4 shows the effect
of an excessive dose of digoxin given after operation to a
patient with rheumatic heart disease treated before operation
with a maintenance dose of 0.1 mg of digitoxin daily. In
this patient, digitalis also depressed AV conduction and
induced an ectopic ventricular rhythm. However, the rate
of the ectopic pacemaker is more rapid than the rate of the
escape pacemaker in the patient without heart disease. Or-
dinary therapeutic doses of digitalis frequently augment or
induce ectopic activity in patients with heart disease (108).
Cardiac surgery. Evaluation of the relation between
arrhythmia and digitalis after cardiac surgery is difficult
because, in these patients, the effects of digitalis are fre-
quently superimposed on the effects of anesthesia, metabolic
abnormalities, fever, surgical trauma and other factors (ref-
erences in reference 4). In one study (99), the frequency of
perioperative arrhythmias was not increased by preoperative
treatment with digitalis in patients with coronary artery dis-
ease undergoing abdominal surgery.
A review ofrecords ofapproximately 400 patients treated
with digitalis after cardiac surgery (4) showed that the ven-
tricular rate was usually more rapid after operation than
before, even when the postoperative maintenance dose of
digitalis was unchanged. The ventricular rate remained rapid
in patients with fever, infection, pulmonary embolism and
post-pericardiotomy syndrome, even when the maintenance
dose of digitalis was increased. In 11 patients with atrial
fibrillation, ventricular rate in excess of 100 beats/min per-
sisted for 2 months to 2 years, even when the maintenance
dose of digoxin was as high as 0.75 mg or 1.0 mg daily.
Of these 11 patients, 10 had intermittent fever due to pul-
monary emboli, pneumonia, pleurisy or postpericardiotomy
syndrome, and 1 had hyperthyroidism. This study (4) sug-
gests that the increased requirement of digitalis in such
patients need not be attributed directly to the operation.
Myocardial infarction. In cats, sensitivity to digitalis
remained unchanged early after coronary artery ligation (109),
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Figure 3. Electrocardiogram of a 17 year old
woman after she attempted to commit suicide
by ingesting 3.0 to 4.0 mg (30 to 40 tablets) of
digitoxin. Upper three strips, recorded on the
day of ingestion, demonstrate depression of si-
noatrial (SA) node activity, supraventricular es-
cape complexes and slowing of ventricular rate
after right carotid (R. Carot.) sinus massage and
after the Valsalva maneuver. Fourth strip, re-
corded on the same day, shows regular sinus
rhythm with a rate of 90 beats/min and a normal
PR interval after intravenous administration of
0.4 mg of atropine sulfate. Two lower strips,
recorded I and 4 days after digitoxin ingestion,
demonstrate persistent depression of SA node
activity and supraventricular escape complexes.
(Reproduced from Fisch C, Surawicz B [4) with
permission. )
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otherstudy (15). the incidenceof digitalis toxicity in patients
with heart disease, including cardiomyopathy, increased only
when their New York Heart Association functional class
was III or IV.
Figure5. Results of two acetylstrophanthidin tolerance tests irl a
patient with myxedema, mitral stenosis and atrial fibrillation before
(0) and after (x) treatment with triiodothyronine. The dose of
acetylstrophanthidin (Ac. Stroph.) inmg is shown onthe abscissa,
and the ventricular rate per minute on the ordinate. The control
rate is 80 beats/min before and 95 beats/min after II · days of
treatment. Note that before treatment, 0.5 mg of acetylstrophan-
thidin slows theventricular rate to 55beats/min. but after treatment
the dose of acetylstrophanthidin needed to slow the ventricular
rate to 65 beats/min is two times larger.
Diseases of Other Organs
Chronic lung disease. There is no agreement about the
digitalis tolerance in patients with chronic pulmonary in-
sufficiency. In one of the early studies (l18), 31% of 122
digitalis-treated patients with chronic cor pulmonale and no
evidence of other heart disease had arrhythmias that were
predominantly supraventricular. In another study (119), 1.32
mg of acetylstrophanthidin was administered to 29 patients
with chronic pulmonary insufficiency. Of these, eight pa-
tients who appearedto have evidenceof increasedsensitivity
to digitalis Were more severely hypoxemic than the patients
without such evidence. These observations suggested an
increased sensitivity to digitalis in the presence of hypoxia.
In another study (120), patients with chronic obstructive
lung disease and severe hypoxemia (Po2 of 31 to 42 mm
Hg) had arrhythmias consistent with digitalis toxicity at
lower than toxic digoxin and digitoxin blood concentrations.
However, other studies (15) showed no evidence of in-
creased digitalis toxicity in patients withchronic lungdisease.
Patients with cor pulmonale frequently have ectopic
supraventricular complexes and rhythms. In such patients,
normaldigitalis doses may increase the rate of ectopic pace-
makers, produce variable degrees of AV block and simulate
digitalis toxicity. Digitalis toxicity may be induced by the
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Figure4. Electrocardiogram (lead III) ofa patient with rheumatic
heart disease and atrial fibrillation treated with a daily 0.1 mg
maintenance dose of digitoxin. Before operation (PRE-OP.) (up-
per strip), well controlled ventricular rate and occasional ven-
tricular premature complexes are seen. After mitral and tricuspid
valve replacement (POST-OP.), the patient received 1.25 mg of
digoxin intravenously. Note ventricular tachycardia at9:00AM and
a slower regular ventricular rhythm, possibly due to exit block, at
10:15 AM.
but increased in the stage of healing infarction (110). In
dogs, digitalis tolerance was decreased early after ligation
of a coronary artery and in the stage of chronic myocardial
infarction (I I I). Patients after myocardial infarction ap-
peared to tolerate the usual therapeutic doses of digitalis
(112) without increase in the incidence of arrhythmias after
digitalis administration. However, in patients withsick sinus
syndrome, caution should be used when administering dig-
italis (113).
During evoiution of experimental myocardial infarction
in pigs, the average toxic dose of acetylstrophanthidin was
reduced by approximately 20% and the digitalis-induced
arrhythmias lasted twice as long as in control or sham-
operated animals (114). In conscious dogs, tolerance to
acetylstrophanthidin decreased within I hour after myo-
cardial infarction by 24%, but returned to control during
the healing phase I week later (lIS) . Studies in vitro (116)
have shown that in cardiac fibers depolarized to a level
positive to - 65 mV, glycosides facilitate undamped oscil-
latory activity. This finding could explain the increased
prevalence of toxic arrhythmias in diseased depolarized
myocardium.
Ina randomized study (JJ7) ofpatients with acute myo-
cardial infarction, treatment with ordinary therapeuticdoses
of digoxin did not change the incidenceor type of ventricular
arrhythmias during the 3 hours after drug administration ,
and there was no evidence that myocardial infarctioncaused
an increasedsensitivity to ordinarydoses of digoxinat serum
digoxin concentrations averaging 1.9 ± 0.7 ng/rnl. In an-
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use of excessive doses given in an attempt to slow the
ventricular rate in patients with pulmonary disease and sinus
tachycardia.
We analyzed some of the factors that precipitated digi-
talis toxicity in 12 patients with severe pulmonary insuffi-
ciency, hypercapnia and severe arterial oxygen unsaturation
(4). Of these 12 patients, digitalis induced atrial tachycardia
with block in 6, AV junctional tachycardia in 3 and multiple
ventricular ectopic beats in the remaining 3. We found that
of these 12 patients, 5 had received excessive doses of
digitalis administered in an attempt to slow the sinus rate,
5 patients had hypokalemia and I had renal insufficiency.
In only I of the 12 patients was there an adequate expla-
nation for the apparently decreased digitalis tolerance. Per-
sonal observations suggest that in patients with chronic cor
pulmonale, hypoxia seldom causes decreased tolerance in
digitalis. In a comprehensive review of the use of digitalis
in patients with pulmonary disease, Green and Smith (121)
pointed out that the studies of digoxin turnover in patients
with cor pulmonale revealed no evidence of changes in drug
metabolism and, thus, no basis for increased sensitivity.
The authors concluded that the following three questions still
need to be answered: I) Is the frequency of arrhythmia in
patients with chronic lung disease increased in the presence
of therapeutic levels of cardiac glycosides? 2) Is there any
correlation between arrhythmia and concurrent use of sym-
pathomimetic drugs used to treat chronic lung disease? 3)
Do patients with stable chronic lung disease have an in-
creased occurrence of digitalis toxicity when the severity of
lung disease, the underlying heart disease and other factors
predisposing to cardiac arrhythmias are taken into account?
Hypo- and hyperthyroidism. Hypothyroidism. The
thyroid function modifies the metabolism of digitalis (6).
Patients with hypothyroidism are said to be more "sensi-
tive" and patients with hyperthyroidism more "resistant"
to digitalis. In patients with hypothyroidism small doses of
digitalis may depress the sinus rate and AV conduction
considerably. Many hypothyroid patients with atrial fibril-
lation do not require digitalis or other drugs to control the
ventricular rate (122). Inothers, rate control can be achieved
by using smaller than customary therapeutic doses. Figure
5 shows the results of an acetylstrophanthidin tolerance test
in a patient with myxedema, mitral stenosis and atrial fi-
brillation not treated with digitalis. The control ventricular
rate was 80 beats/min. After the administration of 0.5 mg
of acetylstrophanthidin, the rate decreased to 55 beats/min
and ventricular premature complexes appeared. After 17
days of treatment with triidothyronine and no digitalis, the
control ventricular rate was 95 beats/min, and a dose of 1.0
mg of acetylstrophanthidin was required to decrease the rate
to 65 beats/min without appearance of ventricular premature
complexes.
Hyperthyroidism. Customary therapeutic doses of digi-
talis produce no effect on the ventricular rate in hyperthyroid
patients with atrial fibrillation. Beta-adrenergicblocking agents
are needed frequently to achieve an adequate slowing of
ventricular rate. Hyperthyroid patients may tolerate larger
than customary therapeutic doses of digitalis, but the safety
of such therapy may be questioned. In hyperthyroid cats,
treatment with digitalis produces myocardial necroses, but
the clinical pertinence of this observation is not certain.
There is no agreement about the mechanisms by which the
thyroid function alters digitalis tolerance. In one study (123),
the excretion rates and the serum half-life of digoxin ap-
peared to be the same in hypo-, hyper- and euthyroid pa-
tients. Therefore, the differences in digoxin concentrations
were attributed to differences in the space of glycoside dis-
tribution, possibly as a result of differences in Na + -K+ -
ATPase activity (I). However, in another study (124), dif-
ferences in serum digoxin concentration correlated with dif-
ferences in creatinine clearance, which was increased in
hyper- and decreased in hypothyroid patients. Since the
digoxin half-life was inversely proportional to creatinine
clearance, the differences in digitalis tolerance could be
attributed to faster glycoside elimination in patients with
hyperthyroidism and slower elimination in those with hy-
pothyroidism (124).
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